LEXICON PHARMACEUTICALS, INC.: share-based compensation expense

What this measure means

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Exact concept: us-gaap:ShareBasedCompensation. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2009-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• LEXICON PHARMACEUTICALS, INC.: total assets
• LEXICON PHARMACEUTICALS, INC.: total liabilities
• LEXICON PHARMACEUTICALS, INC.: stockholders equity
• LEXICON PHARMACEUTICALS, INC.: cash and cash equivalents
• LEXICON PHARMACEUTICALS, INC.: net income or loss
• LEXICON PHARMACEUTICALS, INC.: operating cash flow
• LEXICON PHARMACEUTICALS, INC.: capital expenditure payments
• LEXICON PHARMACEUTICALS, INC.: revenue
• LEXICON PHARMACEUTICALS, INC.: contract revenue excluding tax
• LEXICON PHARMACEUTICALS, INC.: financing cash flow
• LEXICON PHARMACEUTICALS, INC.: investing cash flow
• LEXICON PHARMACEUTICALS, INC.: retained earnings or deficit
• LEXICON PHARMACEUTICALS, INC.: basic weighted-average shares
• LEXICON PHARMACEUTICALS, INC.: diluted weighted-average shares
• LEXICON PHARMACEUTICALS, INC.: basic earnings per share
• LEXICON PHARMACEUTICALS, INC.: diluted earnings per share
• LEXICON PHARMACEUTICALS, INC.: income tax expense or benefit
• LEXICON PHARMACEUTICALS, INC.: net property, plant and equipment
• LEXICON PHARMACEUTICALS, INC.: operating income or loss
• LEXICON PHARMACEUTICALS, INC.: current assets
• LEXICON PHARMACEUTICALS, INC.: interest expense
• LEXICON PHARMACEUTICALS, INC.: current liabilities
• LEXICON PHARMACEUTICALS, INC.: current accounts payable
• LEXICON PHARMACEUTICALS, INC.: goodwill carrying amount
• LEXICON PHARMACEUTICALS, INC.: net finite-lived intangible assets
• LEXICON PHARMACEUTICALS, INC.: net current accounts receivable
• LEXICON PHARMACEUTICALS, INC.: common-stock repurchase payments
• LEXICON PHARMACEUTICALS, INC.: operating expenses
• LEXICON PHARMACEUTICALS, INC.: net inventory
• LEXICON PHARMACEUTICALS, INC.: selling, general and administrative expense
• LEXICON PHARMACEUTICALS, INC.: research and development expense

Inspect the source

Entity

LEXICON PHARMACEUTICALS, INC. / CIK 0001062822

Captured

2026-09-20T05:18:38.377Z

SEC response SHA-256

6892e4a70040629ec55c0f3f5c93b207e6e0406bb1510e70eff56172a2cc9a0b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001062822.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))